Back
The Duckhorn Portfolio Vs. Longboard Pharmaceuticals Industry Stock Comparison
Sell
22
NAPA
The Duckhorn Portfolio
Last Price:
5.94
Seasonality Move:
-11.51%
Sell
42
LBPH
Longboard Pharmaceuticals
Last Price:
33.39
Seasonality Move:
-17.05%
Sell
22
The Duckhorn Portfolio (NAPA)
is a Sell
Is The Duckhorn Portfolio a Buy, Sell or Hold?
- The current The Duckhorn Portfolio [NAPA] share price is $5.88. The Score for NAPA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- NAPA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Longboard Pharmaceuticals (LBPH)
is a Sell
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $29.31. The Score for LBPH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- LBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NAPA Stock Price Chart
What is The Duckhorn Portfolio's stock price today?
-
The The Duckhorn Portfolio share price today is $5.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NAPA is experiencing slight selling pressure.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $29.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
NAPA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 37.28 | Sell |
Chaikin Money Flow: | -275092 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.87 - 6.65) | Sell |
Bollinger Bands (100): | (6.46 - 7.92) | Sell |
LBPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.06 | Sell |
Relative Strength Index (14 RSI): | 38.7 | Sell |
Chaikin Money Flow: | 434120 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.2 - 36.44) | Sell |
Bollinger Bands (100): | (20.78 - 35.78) | Buy |
NAPA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.81 | Buy |
20-day SMA: | 6.14 | Sell |
50-day SMA: | 6.67 | Sell |
200-day SMA: | 8.17 | Sell |
8-day EMA: | 5.86 | Buy |
20-day EMA: | 6.1 | Sell |
50-day EMA: | 6.56 | Sell |
200-day EMA: | 8.24 | Sell |
LBPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.33 | Sell |
20-day SMA: | 34.08 | Sell |
50-day SMA: | 34.97 | Sell |
200-day SMA: | 23.09 | Buy |
8-day EMA: | 31.57 | Sell |
20-day EMA: | 33.23 | Sell |
50-day EMA: | 32.69 | Sell |
200-day EMA: | 24.04 | Buy |
The Duckhorn Portfolio Earnings Growth & NAPA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.07 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
The Duckhorn Portfolio Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Longboard Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |